- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03254095
Predictors of Skin Temperature, Plantar Pressure and Ulceration in Diabetic Foot Patients.
Thermal and Biomechanical Characterization of Diabetic Foot Patients, Predictors of Skin Temperature, Barefoot Plantar Pressure and Ulceration.
Diabetes is a chronic disease with increasing prevalence worldwide with a high burden to individuals and the society and it is expected to be the 7th leading cause of death in 2030. Diabetes related complications manifest in many body parts, often in the foot, due to reduced blood flow and nerve damage, increasing the risk of ulcers and amputation. High plantar pressures during walking contribute to the development of foot ulcers and foot ulcer recurrence. Emerging studies also point skin temperature as another predictor of foot ulceration. However, the number of studies including prediction models of plantar pressure and skin temperature are scarce, especially in patients with confirmed diagnosis of diabetic foot and a history of foot ulcer. Factors like mobility, hardness of plantar soft tissue, foot deformities and other diabetes related characteristics have been related to plantar pressure measurements but not to foot skin temperature measurements, and the relation between skin temperature and plantar pressure has not been much explored in the literature. The role of these variables in the development of foot ulceration needs further attention, especially in patients with history of foot ulcers has they are at the highest risk to develop a foot ulcer.
Therefore, the goal of this research is to determine which variables can be used to predict plantar pressure and skin temperature and which factors are associated with the development of foot ulcers in patients with established diagnosis of diabetic foot. The associations between skin temperature and plantar pressure will also be addressed.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adults (over 18 years)
- Diagnosed as diabetic foot patient
- Able to walk 10 meters without assistance
Exclusion Criteria:
- Non-cooperating patients
- Patients with major amputations
- Patients with a draining ulcer and/or infection
- Patients with cognitive impairments
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Skin temperature
Time Frame: At study entry
|
After an acclimation period of 10 minutes, skin temperature of the sole and dorsum of the foot will be assessed with a thermographic camera.
Thermograms will be captured before, immediately after and five minutes after a two-minute cold stress test using an aluminium plaque.
|
At study entry
|
|
Barefoot plantar pressure
Time Frame: At study entry
|
Barefoot plantar pressure will be assessed using a pressure platform.
|
At study entry
|
|
Percentage of patients developing a foot ulcer
Time Frame: One year after enrollment
|
The occurrence of foot ulceration will be assessed during a period of 1 year.
|
One year after enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ankle mobility
Time Frame: At study entry
|
Active ankle mobility (dorsiflexion and plantarflexion) will be assessed with a goniometer.
|
At study entry
|
|
Hallux active extension range of movement
Time Frame: At study entry
|
Hallux active extension mobility will be assessed with a goniometer.
|
At study entry
|
|
Soft tissue hardness
Time Frame: At study entry
|
Soft tissue hardness will be assessed with a durometer.
|
At study entry
|
|
In-shoe plantar pressure
Time Frame: At study entry
|
In-shoe plantar pressure will be assessed using an insole system.
|
At study entry
|
|
Time to ulceration
Time Frame: At study entry
|
The time to ulcer occurrence will be assessed.
|
At study entry
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Disease duration
Time Frame: At study entry
|
Diabetes duration until the assessment day will be noted.
|
At study entry
|
|
Type of diabetes
Time Frame: At study entry
|
The type of diabetes (Type I or Type II) will be assessed.
|
At study entry
|
|
Foot deformity
Time Frame: At study entry
|
The presence of claw toes, hammer toes, hallux valgus, flat foot, increased foot arch and Charcot will be assessed.
|
At study entry
|
|
Amputation
Time Frame: At study entry
|
The presence of minor amputation will be assessed.
|
At study entry
|
|
Neuropathy
Time Frame: At study entry
|
The presence of neuropathy will be assessed according to the criteria of the International Working Group on the Diabetic Foot.
|
At study entry
|
|
Peripheral artery disease
Time Frame: At study entry
|
Peripheral artery disease signs - an absence of foot pulses and intermittent claudication - will be assessed.
|
At study entry
|
|
Generic health status
Time Frame: At study entry
|
The generic health status will be assessed with the EQ-5D-5L instrument.
|
At study entry
|
|
Age
Time Frame: At study entry
|
The age of participants at the assessment day will be noted.
|
At study entry
|
|
Height
Time Frame: At study entry
|
The height of participants at the assessment day will be noted.
|
At study entry
|
|
Weight
Time Frame: At study entry
|
The weight of participants at the assessment day will be noted.
|
At study entry
|
|
Body mass index
Time Frame: At study entry
|
Body mass index will be calculated from the height and weight of the participants.
|
At study entry
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Adérito RD Seixas, MSc, Universidade do Porto
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FADEUP_PhD_AdéritoSeixas#1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of North Carolina, Chapel HillAmerican Diabetes AssociationNot yet recruitingType 2 Diabetes Mellitus (T2DM) | Diabetes (DM) | Insulin Dependent Diabetes | Type 1 Diabetes (T1D) | Diabetes Education | Diabetes Care | Diabetes (Insulin-requiring, Type 1 or Type 2)United States
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
-
Garvan Institute of Medical ResearchWeizmann Institute of ScienceCompletedType 2 Diabetes Mellitus | Pre DiabetesAustralia